BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

331 related articles for article (PubMed ID: 15282962)

  • 41. Dapsone drug resistance in the MDT era.
    Roche PW; Neupane KD; Failbus SS; Butlin CR
    Int J Lepr Other Mycobact Dis; 2000 Sep; 68(3):323-5. PubMed ID: 11221097
    [No Abstract]   [Full Text] [Related]  

  • 42. Drug susceptibility of Mycobacterium leprae: a retrospective analysis of mouse footpad inoculation results from 1983 to 1997.
    Sekar B; Elangeswaran N; Jayarama E; Rajendran M; Kumar SS; Vijayaraghavan R; Anandan D; Arunagiri K
    Lepr Rev; 2002 Sep; 73(3):239-44. PubMed ID: 12449888
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Drug resistance in Mycobacterium leprae from patients with leprosy in China.
    Liu D; Zhang Q; Sun Y; Wang C; Zhang Y; Fu X; Chen M; Zhou G; Yu X; Wang J; Liu H; Zhang F
    Clin Exp Dermatol; 2015 Dec; 40(8):908-11. PubMed ID: 25991507
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Present situation of leprosy in Japan, 2006-2010: analysis of drug resistance in new registered and relapsed cases by molecular biological methods.
    Mori S; Yotsu RR; Suzuki K; Makino M; Ishii N
    J Dermatol Sci; 2012 Sep; 67(3):192-4. PubMed ID: 22739027
    [No Abstract]   [Full Text] [Related]  

  • 45. Prospects for chemotherapy of leprosy.
    Ji B
    Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
    [No Abstract]   [Full Text] [Related]  

  • 46. Multiple mutations in the rpoB gene of Mycobacterium leprae strains from leprosy patients in Thailand.
    Ramasoota P; Wongwit W; Sampunachot P; Unnarat K; Ngamying M; Svenson SB
    Southeast Asian J Trop Med Public Health; 2000 Sep; 31(3):493-7. PubMed ID: 11289008
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drug resistance in leprosy.
    Ghosh S
    Indian J Dermatol; 1980 Jul; 25(3):1-4. PubMed ID: 7026426
    [No Abstract]   [Full Text] [Related]  

  • 48. Report of 2 indigenous cases of leprosy from a European country: use of polymerase chain reaction-restriction fragment length polymorphism analysis of hsp65 gene for identification of Mycobacterium leprae directly from a clinical sample.
    Neonakis IK; Gitti Z; Kontos F; Baritaki S; Zerva L; Krambovitis E; Spandidos DA
    Diagn Microbiol Infect Dis; 2009 Jul; 64(3):331-3. PubMed ID: 19376672
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Use of polymerase chain reaction to assess efficacy of leprosy chemotherapy.
    Jamil S; Keer JT; Lucas SB; Dockrell HM; Chiang TJ; Hussain R; Stoker NG
    Lancet; 1993 Jul; 342(8866):264-8. PubMed ID: 8101301
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Mycobacterium leprae genome sequence; a landmark achievement.
    Colston MJ
    Lepr Rev; 2001 Dec; 72(4):385-6. PubMed ID: 11826474
    [No Abstract]   [Full Text] [Related]  

  • 51. [Multi-drug resistant Mycobacterium leprae from patients with leprosy].
    Maeda S
    Nihon Hansenbyo Gakkai Zasshi; 2004 Sep; 73(3):227-33. PubMed ID: 15508725
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Case Report: Multidrug-Resistant
    Kamat D; Narang T; Ahuja M; Lavania M; Dogra S
    Am J Trop Med Hyg; 2020 Apr; 102(4):724-727. PubMed ID: 32043454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A second case of multidrug-resistant Mycobacterium leprae isolated from a Japanese patient with relapsed lepromatous leprosy.
    Matsuoka M; Kashiwabara Y; Liangfen Z; Goto M; Kitajima S
    Int J Lepr Other Mycobact Dis; 2003 Sep; 71(3):240-3. PubMed ID: 14608820
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Mutation at codon 442 in the rpoB gene of Mycobacterium leprae does not confer resistance to rifampicin.
    Lavania M; Hena A; Reja H; Nigam A; Biswas NK; Singh I; Turankar RP; Gupta U; Kumar S; Rewaria L; Patra PK; Sengupta U; Bhattacharya B
    Lepr Rev; 2016 Mar; 87(1):93-100. PubMed ID: 27255062
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of mono treatment and combined treatment on the morphology of Myco. lepare in the skin.
    Leiker DL
    Lepr Rev; 1975 Jun; 46(2 Suppl):73-9. PubMed ID: 1100967
    [No Abstract]   [Full Text] [Related]  

  • 56. [Comparative characterization of the antigenic composition of M. leprae and M. lufu].
    Salamatina OS; Diachina MN; Iushchenko AA; Chernousova LN; Kalinina ON; Parshin MP
    Probl Tuberk; 2001; (8):49-51. PubMed ID: 11767394
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Polymerase chain reaction and assessment of leprosy chemotherapy.
    Mistry NF; Antia NH
    Lancet; 1993 Oct; 342(8878):1060. PubMed ID: 8105297
    [No Abstract]   [Full Text] [Related]  

  • 58. Improved protocol for PCR detection of Mycobacterium leprae in buffered formalin-fixed skin biopsies.
    Singh HB; Katoch VM; Natrajan M; Sharma VD; Chauhan DS; Lavania M; Sharma P; Sharma M; Katoch K; Benara S; Singh P
    Int J Lepr Other Mycobact Dis; 2004 Jun; 72(2):175-8. PubMed ID: 15301582
    [No Abstract]   [Full Text] [Related]  

  • 59. Dapsone resistance does not appear to be associated with a mutation in the dihydropteroate synthase-2 gene of Mycobacterium leprae.
    Gillis TP; Williams DL
    Indian J Lepr; 1999; 71(1):11-8. PubMed ID: 10439322
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Treatment failure in leprosy.
    Levy L
    Int J Lepr Other Mycobact Dis; 1976; 44(1-2):177-82. PubMed ID: 776854
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.